Loading…

Assoc. Prof. Preecha Montakantikul

Department of Pharmacy


  preecha.mon@mahidol.ac.th

Education Background

  • B.Sc. in Pharm (Chulalongkorn University, Thailand)
  • Doctor of Pharmacy (University of Illinois at Chicago, USA)
  • Certified Pharmacy Practice Resident (University of Illinois at Chicago, USA)
  • Certified Pediatric Pharmacy Resident (University of Illinois at Chicago, USA)
  • Board certified pharmacotherapy specialist (Board of Pharmaceutical Specialty, USA)
  • Board certified pharmacotherapy (Pharmacy council, Thailand)

Work Experience

  • Associate Professor at the Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 2014-present
  • Assistant Professor at the Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 2001-2014
  • Lecturer at the Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 1994-2001
  • Pharmacist at Senangkhanikhom Hospital, Amnat Charoen, 1991-1993

Expertise

  • Antibiotic Stewardship
  • Monte Carlo Simulation
  • Pharmacokinetic and pharmacodynamic properties of anti-infective agents
  • Pharmaceutical care

Award & Honor

Outstanding Lecturer, Mahidol University, 2010

Current Research

  1. Thirapanmethee K, Srisiri-A-Nun T, Houngsaitong J, Montakantikul P, Khuntayaporn P, Chomnawang MT. Prevalence of OXA-Type β-Lactamase Genes among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates in Thailand. Antibiotics (Basel). 2020 Dec 3;9(12):E864. doi: 10.3390/antibiotics9120864.
  2. Houngsaitong J, Montakantikul P, Paiboonwong1 T, Chomnawang M, Khuntayaporn P, Chulavatnatol S. In vitro activity of biapenem and comparators against multidrug-resistant and carbapenem-resistant Acinetobacter baumannii isolated from tertiary care hospitals in Thailand. Pharm Sci Asia 2020; 47(4), 378-386. DOI: 10.29090/psa.2020.04.019.0072
  3. Leelawatanachai P, Wattanavijitkul T, Paiboonvong T, Plongla R , Chatsuwan T, Usayaporn S, Nosoongnoen W, Montakantikul P.Evaluation of Intravenous Fosfomycin Disodium Dosing Regimens in Critically Ill Patients for Treatment of Carbapenem-Resistant Enterobacterales Infections Using Monte Carlo Simulation. Antibiotics 2020, 9, 615; doi:10.3390/antibiotics9090615.
  4. Khan-asa B, Punyawudho B, Singkham N, Chaivichacharn P, Karoopongse E, Chayakulkeeree M, Montakantikul P. Impact of Albumin and Omeprazole on Steady-State Population Pharmacokinetics of Voriconazole and Development of a Voriconazole Dosing Optimization Model in Thai Patients with Hematologic Diseases. Antibiotics 2020: 9, 574; doi:10.3390/antibiotics9090574www.mdpi.com.
  5. Surapat, B., Montakantikul, P., Malathum, K. et al. Microbial epidemiology and risk factors for relapse in gram-negative bacteria catheter-related bloodstream infection with a pilot prospective study in patients with catheter removal receiving short-duration of antibiotic therapy. BMC Infect Dis 20, 604 (2020). https://doi.org/10.1186/s12879-020-05312-z
  6. Rodjun V, Houngsaitong J, Montakantikul P, Paiboonvong T, Khuntayaporn P, Yanyongchaikit P, Sriyant P. In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods. Antibiotics 2020;9:516; doi:10.3390/antibiotics9080516.
  7. Lertwattanachai T, Montakantikul P, Tangsujaritvijit V, Sanguanwit P, Sueajai J, Auparakkitanon S, Dilokpattanamongkol P. Clinical outcomes of empirical high dose meorpenem in critically ill patients with sepsis and septic shock: a randomized controlled trial. J Intensive Care 2020:8:26:1-10.
  8. Paiboonvong T, Rodjun V, Houngsaitong J, Chomnawang M, Montakantikul P, Chulavatnatol S. Comparative in vitro activity of sitafloxacin against multidrug-resistant and carbapenem-resistant Acinetobacter baumannii clinical isolates in Thailand. Pharm Sci Asia 2020;47:37-42.
  9. Jitaree K, Sathirakul K, Houngsaitong J, Asuphon O, Saelim W, Thamlikitkul V, Montakantikul P. Pharmacokinetic/Pharmacodynamic (PK/PD) simulation for dosage optimization of colistin against Carbapenem-Resistant Klebsiella pneumoniae  and Carbapenem-Resistant Escherichia coli . Antibiotics 2019;8(3):125; https://doi.org/10.3390/antibiotics8030125 .
  10. Paiboonvong T,  Nosoongnoen W, Sathirakul K, Tangsujaritvijit V, Kaemapairoj J, Tragulpiankit P, Montakantikul P. Pharmacokinetics and Penetration of Sitafloxacin into Alveolar Epithelial Lining Fluid in Thai Critically Ill Patients with Pneumonia. Antimicrob Agents Chemother 2019:63(10):e00800-19. DOI: 10.1128/AAC.00800-19
  11. So-ngern A, Leelasupasri S, Chulavatnatol S, Pummangura C, Bunupuradah P, Montakantikul P. Prognosis Value of Serum Procalcitonin for Diagnosis of Bacterial Infections in Critically ill Patients. Infect Chemother  2019;51(3):263-73.
  12. Setiawan E, Suwannoi L, Montakantikul P, Chindavijak B. Optimization of Intermittent Vancomycin Dosage Regimens for Thai Critically Ill Population Infected by MRSA in the Era of the “MIC Creep” Phenomenon. Act Medica Indonesiana 2019;51(1):10-8.
  13. Choorassamee J, Sonthisombat P, Kiraatisin P, Montakantikul P. Pharmacodynamic-based dosage regimens for imipenem meropenem and doripenem to treat melioidosis: a Monte Carlo Simulation. Southeast  Asian  J  Trop Med Public Health 2019;50(2):275-82.
  14. Leelawattanachai P, Montakantikul P, Nosoongnoen W, Chayakulkeeree M. Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis. Ther Clin Risk Manag 2019;15:589-95.
  15. Prakobsrikul N, Malathum K, Santanirand P, Chumnumwat S, Piebpien P, Montakantikul P. Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a University Hospital, Thailand. J Clin Pharm Ther 2019 Apr;44(2):292-299.
  16. Bubpamala J, Khuntayaporn P, Thirapanmethee K, Montakantikul P, Santanirand P, Chomnawanf MT. Phenotypic and genotypic characterizations of extended-spectrum beta-lactamase-producing Escherichia coli in Thailand. Infection and Drug Resistance 2018;11: 2151–7.
  17. Setiasuwan E, Montakantikul P. Pharmacokinetic and Pharmacodynamic Approach in Adult Critically-Ill Patients Treated with Standard Dose of Vancomycin for MRSA Infection. J Med Assoc Thai 2018;101(5):1-9.
  18. Paiboonvong T, Pummangura C, Tedtaisong P, Thamlikitkul V, Tragulpiankit P, Suansanae T, Sukka S, Montakantikul P. Education on antimicrobials, antimicrobial resistance, and infectious diseases in pharmacy curricula, Thailand. Pharm Sci Asia 2018; 45 (2), 105-13.
  19. Jannual S, Montakantikul P, Huangsaitong J, Thamalikitkul V, Sonthisombat P. Pharmacodynamic Evaluation of Oral Amoxicillin, Amoxicillin/Clavulanate, Cefditoren, and Azithromycin Against Streptococcus pneumoniae-Caused Respiratory Tract Infections: A Monte Carlo Simulation. J Med Assoc Thai 2018;101(3):305-12.
  20. Songern A, Khan-asa B, Montakantikul P, Manosuthi W. Dyslipidemia among Thai HIV-infected  adults receiving antiretroviral therapy: one hospital-based report. Southeast Asian J Trop Med Public Health 2018;49(1):1-8.
  21. Dilokpattanamongkol P , Chumnumwat S , Takultacha S ,  Songsomboon S , Montakarntikul P , Lekpittaya N, Sa-ngasoongsong P, Sumritpradit P. Guideline Concordance Evaluation of Antimicrobial Usage in Surgical Patients at University Hospital, Thailand. J Med Assoc Thai 2017; 100 (11):32.
  22. Sukkha S, Chindavijak B, Montakantikul P, Ingsathit A, Nosoongnoen W, Sumethkul V. Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study. Int J Clin Pharm. 2017 Dec;39(6):1298-1303.
  23. Asuphon O, Montakantikul P, Houngsaitong J, Kiratisin P, Sonthisombat P. Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation. Int J Infect Dis 2016; 50:23-9.
  24. Montakantikul P, Puttipokin K, Watcharananan SP, Chulavatanatol C. Safety profile of voriconazole in Thai patients: A retrospective, descriptive Study. Songkla Med J 2015;33(3):153-63.
  25. Kunakonvichaya B, Thirapanmethee K, Khuntayaporn P, Montakantikul P, Chomnawang MT. Synergistic effects of fosfomycin and carbapenems against carbapenem-resistant Pseudomonas aeruginosa clinical isolates. Int J Antimicrob Agents 2015 May;45(5):556-7.
  26. Kristina SA, Thavorncharoensap M, Pongcharoensuk P, Montakantikul P, Suansanae T, Prabandari YS. Effectiveness of tobacco education for pharmacy students in Indonesia. Asian Pac J Cancer Prev. 2014;15(24):10783-6.
  27. So-Ngern A, Montakantikul P, Manosuthi W. Clinically significant drug interactions among HIV-infected patients receiving antiretroviral therapy. Southeast Asian J Trop Med Public Health 2014;45(5):1023-31.
  28. Khuntayaporn P, Montakantikul P, Santanirand P, Kiratisin P, Chomnawang MT. Molecular investigation of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa isolated clinically in Thailand. Microbiol Immunol 2013; 57 (10):170-8.
  29. Khuntayaporn P, Montakantikul P, Mootsikapun P, Thamlikitkul V,  Chomnawang MT. Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across Thailand. Ann Clin  Microbiol Antimicrob 2012;11:25.
  30. Monmaturapoj T, Montakantikul P, Mootsikapun P, Tragulpiankit P. A prospective, randomized, double dummy, placebo-controlled trial of oral cefditoren pivoxil 400 mg once daily as switch therapy after intravenous ceftriaxone in the treatment of acute pyelonephritis. Int J Infect Dis 2012; 16: e843-e849.
  31. Bhumibhamon N, Montakantikul P, Sangtawesin V, Suksomboon N. Study of  medication reconciliation process in pediatrics medical wards at Queen Sirikit National Institute of Child Health. Thai Pediatr J 2012; 19(1): 23-9.
  32. Tragulpiankit P, Montakatikul P, Chulavatnatol S, Chansirikanrnjana S, Thawinwang A. Measured versus estimated creatinine clearance in elderly patients. J App Ther Res 2011:8(2):43-51.
  33. Robert JA, Kwa A, Montakantikul P, Gomersall C, Kuti JL, Nicolau DP. Pharmacodynamic profiling of intravenous antibiotics against prevalent gram-negative organisms across the globe: the PASSPAORT program-Asia-Pacific-region. Int J Antimicrob Agents 2011;37:225-9.
  34. Chindavijak B, KomindrS, Ritsri W, Montakantikul P.  Effects of changes in patients’ nutritional status upon complications, clinical outcomes, length of hospital stay and hospital expense. Thai Journal of Clinical Nutrition 2009; 3(2): 81-5.
  35. Paiboonvong T, Montakantikul P, Chansirikarnjana S, Tragulpiankit P.  Incidence of Medication Errors in Medication Reconciliation at General Medical Wards, Ramathibodi Hospital. Mahidol University J Pharm Sci 2009; 36 (1-4), 44-9.
  36. Piebpien P, Tragulpiankit P, Preutthipan A, Montakantikul P. Drug Therapy Problem Management by Pharmacist in Paediatric Intensive Care Unit at a Large Teaching Hospital, Thailand. Drug Safety 2007;30(10):949.
  37. Kraitep T, Chulavatnatol S, Montakantikul P, Srisan P, Lochindarat S. Role of Pharmacist in clinical pharmacy services in pediatric intensive care unit at Queen Sirikit National Institute of Child Health. Thai Pediatr J 2006;13(2):176-9.
  38. Tragulpiankit P, Pummangura C, Luscombe DK, Kaojarern S, Wananukul W, Montakantikul P, Nathisuwan S. Prevention of adverse drug reactions in hospitalised patients by pharmacist participation at a large teaching hospital in Thailand. Drug Safety 2005;28(10):931.
  39. Sangsiri S, Tengapichat W, Bunnag P, Montakantikul P, Suksomboon N. Epidemiology of antidiabetic drug therapy in type 2 diabetes. J Med Tech Assoc Thai  2005;33(3):1271-80.
  40. Pummangura C, Tragulpiankit P, Kaojarern S, Wananukul W, Montakantikul P, Luscombe DK, Pomyen N. Characteristics of adverse drug reactions and patient at risk in medical wards. Pharmacy World & Science 2004;26:A100.
  41. มนทรัตม์ ถาวรเจริญทรัพย์ ปรีชา มนทกานติกุล พัชราภรณ์ เยี่ยมสวัสดิ์ วีนัส ขุติมานิตสกุล. การสำรวจการยอมรับและความคิดเห็นของเภสัชกรต่อการศึกษาต่อเนื่องทางเภสัชศาสตร์.วารสารเภสัชกรรมโรงพยาบาล 2547; 14(3): 225-233.
  42. Prathanturaruk S, Korsanan S, Montakantikul P, Tawapunkul N, Pajongruk M. Counseling for herbal products by community pharmacists. J Health Sci 2004;13:804-12. (Thai version).
  43. Suksomboon N, Petchudomsinsuk W, Montakantikul P, Lerdluedeeporn P.  Impact of Pharmacist Intervention in Pediatric Asthma Patients: A Randomised Controlled Trial.  Mahidol J Pharm Sci 2003;30(2):11-16.
  44. Pummangura C, Tragulpiankit P, Kaojaroen S, Wananukul W, Montakantikul P, Luscombe DK, Pomyen N. Characteristics of adverse drug reactions and patients at risk in medical wards, Ramathibodi Hospital. Mahidol University Journal of Pharmaceutical Sciences 2003;30(3):25-31.
  45. Montakantikul P , Srivilaicharoeng A, Surametheekul S, Kumnunsap S, Reungchareungrung K. Preliminary report of risk factors associated nephrotoxicity from aminoglycosides. Thai J Hosp Pharm 2000;10(4):188-99. (Thai version).

Publication

Year 2026

1.

Dose Optimization of Piperacillin for Pseudomonas aeruginosa Infection in Febrile Neutropenic Pediatric Patients

Supapon C, Sitaruno S, Pattharachayakul S, Montakantikul P, Boonpeng A.
European Journal of Drug Metabolism and Pharmacokinetics 2026 Jan 3 , 2026.

Year 2025

2.

Dosage Regimen Optimization of Ertapenem Against ESBL-Producing Enterobacterales Infection in Critically Ill Patients Using Monte Carlo Simulation

Muangkasem A; Nosoongnoen W; Sririttha S; Aramruang T; Montakantikul P.
Clinical and Translational Science 2025 Jun 27;15(27):21962-21976 , 2025.

3.

Population Pharmacokinetics and Pharmacodynamics of Sitafloxacin in Plasma and Alveolar Epithelial Lining Fluid of Critically Ill Thai Patients With Pneumonia

Paiboonvong T, Montakantikul P, Panjasawatwong N, Singkham N, Punyawudho B.
Pharmacology Research & Perspectives 2025 Apr;13(2):e70081 , 2025.

Year 2024

4.

An analysis of attitudes, knowledge, and willingness of Thai pharmacists as vaccinators: A nationwide survey study

Chumnumwat S; Montakantikul P; Wongpakwat J; Siriwannapha N; Pitaknitinun K.
JACCP Journal of the American College of Clinical Pharmacy 2024; 7():376-383 , 2024.

5.

Comparison of lactate clearance between high-dose and conventional-dose of meropenem in sepsis and septic shock patients at emergency department; post-hoc analysis of a randomized controlled trial

Sanguanwit P; Montakantikul P; Damrongkulchart P; Lertwattanachai T; Tangsujaritvijit V; Dilokpattanamongkol P.
Pharmaceutical Sciences Asia 2024; 51():125-132 , 2024.

6.

Mortality factors and antibiotic options in carbapenem-resistant Enterobacterales bloodstream infections: Insights from a high-prevalence setting with co-occurring NDM-1 and OXA-48

Karnmueng P, Montakantikul P, Paiboonvong T, Plongla R, Chatsuwan T, Chumnumwat S.
Clin Transl Sci 2024 Jun;17(6):e13855 , 2024.

Year 2023

7.

A randomized, controlled trial of prulifloxacin as conversion therapy after intravenous carbapenem in the treatment of acute pyelonephritis caused by third generation cephalosporin resistant pathogens: A pilot study

So-Ngern A; Jirajariyavej S; Thuncharoon H; Khunthupat N; Chantarojanasiri T; Montakantikul P.
Clinical and Translational Science 2023 Oct 18 , 2023.

8.

Comparison of the mathematical equation and trapezoidal approach for 24h area under the plasma concentration-time curve calculation in patients who received intravenous vancomycin in an acute care setting

Chanapiwat P, Paiboonvong T, Rattanaumpawan P, Montakantikul P.
Pharmacology research & perspectives 2023 Feb;11(1):e01046 , 2023.

9.

Drug-related problems identified by clinical pharmacists in an academic medical centre in Thailand

Lekpittaya N, Kocharoen S, Angkanavisul J, Siriudompas T, Montakantikul P, Paiboonvong T.
J Pharm Policy Pract 2023 Dec 16;17(1):2288603 , 2023.

10.

Optimal dosing regimen of biapenem and fosfomycin sodium combination against multidrug resistant Acinetobacter baumannii infection in pediatric patients using Monte Carlo simulation

Tangtrakultham S, Houngsaitong J, Sathirakul K, Nosoongnoen W, Chumnumwat S, Montakantikul P.
Pharmaceutical Sciences Asia , 2023.

11.

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii

Rodjun V; Montakantikul P; Houngsaitong J; Jitaree K; Nosoongnoen W.
Frontiers in Microbiology 2023 Dec;61(1):189-200 , 2023.

Year 2022

12.

Chloroquine dosage regimen simulation for pediatric patients with coronavirus disease 2019

Koyratkoson K, Tidwong N, Tangtrakultham S, Montakantikul P.
Pharmaceutical Sciences Asia 2022; 49():312-322 , 2022.

13.

Correlation between Carbapenem Consumption and Carbapenems Susceptibility Profiles of Acinetobacter baumannii and Pseudomonas aeruginosa in an Academic Medical Center in Thailand

Paiboonvong T, Tedtaisong P, Montakantikul P, Gorsanan S, Tantisiriwat W.
Antibiotics 2022 May;43(9-10):939-954 , 2022.

14.

Current data on Covid-19 vaccine in pediatrics

Treerattanapun L, Montakantikul P.
Pharmaceutical Sciences Asia 2022; 49():15-21 , 2022.

15.

Impact of an infectious diseases pharmacist-led intervention on antimicrobial stewardship program guideline adherence at a Thai medical center

Jantarathaneewat K, Montakantikul P, Weber DJ, Nanthapisal S, Rutjanawech S, Apisarnthanarak A.
Am J Health Syst Pharm 2022 Jul 22;79(15):1266-1272 , 2022.

16.

Optimizing hydroxychloroquine dosing regimen for treatment of pediatric patients with coronavirus disease 2019 using Monte Carlo simulation

Treerattanapun L, Tangtrakultham S, Tidwong N, Montakantikul P.
Pharmaceutical Sciences Asia 2022; 49():22-33 , 2022.

17.

The Evaluation of Meropenem Dosing Regimens Against ESBL-Producing Escherichia coli in ICU Patients Using Monte Carlo Simulation

Win EE, Htun KW, Tragulpiankit P, Tangtrakultham S, Montakantikul P.
Infection and Drug Resistance 2022 Feb 11;15:439-453 , 2022.

Year 2021

18.

Colistin dosing regimens against pseudomonas aeruginosa in critically ill patients: An application of monte carlo simulation

Nguyen VTK, Montakantikul P, Tragulpiankit P, Houngsaitong J, Shuib MF..
Antibiotics 2021; 10(5): 595., 2021.

19.

Efficacy comparison between oral erythromycin versus domperidone for the treatment of feeding intolerance in preterm neonates

Sukwuttichai P, Boonkasidecha S, Montakantikul P, Vimolsarawong N..
Pediatrics and Neonatology 2021; 62(5): 543-549., 2021.

20.

Guideline concordance of bisphosphonates used for osteoporosis in a university hospital, Thailand

Anusathitwattana S, Sa-ngasoongsong P, Montakantikul P, Lekpittaya N, Chindavijak B*..
Pharmaceutical sciences asia 2021; 48(1): 52-60., 2021.

21.

Optimized chloroquine phosphate dosage regimens for early virological clearance of severe acute respiratory syndrome coronavirus 2 using monte carlo simulation

Tidwong N, Punyawudho B, Leelawattanachai P, Tangtrakultham S, Dilokpattanamongkol P, Paiboonvong T, Chumnumwat S, Montakantikul P*..
Pharmaceutical Sciences AsiaPharmaceutical Sciences Asia 2021; 48(3): 291-299., 2021.

22.

Optimized dosing regimen of hydroxychloroquine for treatment of coronavirus disease 2019 using Monte Carlo simulation

Leevanichchakhul S, Dilokpattanamongkol P, Paiboonvong T, Tangtrakultham S, Chumnumwat S, Kiertiburanakul S, Montakantikul P*..
Pharmaceutical Sciences Asia 2021; 48(5): 425-431., 2021.

23.

Pharmacist-driven antibiotic stewardship program in febrile neutropenic patients: A single site prospective study in Thailand

Jantarathaneewat K, Apisarnthanarak A, Limvorapitak W, Weber DJ, Montakantikul P*.
Antibiotics 2021; 10(4): 456., 2021.

24.

Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: A nationwide study

Khuntayaporn P, Kanathum P, Houngsaitong J, Montakantikul P, Thirapanmethee K, Chomnawang MT*..
Ann clin microbiol antimicrob 2021; 20(1):19., 2021.

Year 2020

25.

Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: A randomized controlled trial

Lertwattanachai T, Montakantikul P, Tangsujaritvijit V, Sanguanwit P, Sueajai J, Auparakkitanon S, Dilokpattanamongkol P*..
Journal of intensive care 2020; 8(1): 26., 2020.

26.

Comparative in vitro activity of sitafloxacin against multidrug-resistant and carbapenem-resistant Acinetobacter baumannii clinical isolates in Thailand

Paiboonvong T, Rodjun V, Houngsaitong J, Chomnawang M, Montakantikul P, Chulavatnatol S*..
Pharmaceutical sciences asia 2020; 47(1): 37-42., 2020.

27.

Evaluation of intravenous fosfomycin disodium dosing regimens in critically ill patients for treatment of carbapenem-resistant enterobacterales infections using monte carlo simulation

Leelawattanachai P, Wattanavijitkul T, Paiboonvong T, Plongla R, Chatsuwan T, Usayaporn S, Nosoongnoen W, Montakantikul P*..
Antibiotics 2020; 9(9): 615: 1-14., 2020.

28.

Impact of albumin and omeprazole on steady-state population pharmacokinetics of voriconazole and development of a voriconazole dosing optimization model in thai patients with hematologic diseases

Khan-Asa B, Punyawudho B, Singkham N, Chaivichacharn P, Karoopongse E, Chayakulkeeree M*, Montakantikul P..
Antibiotics 2020; 9(9): 574: 1-14., 2020.

29.

In vitro activities of colistin and sitafloxacin combinations against multidrug-, carbapenem-, and colistin-resistant acinetobacter baumannii using the broth microdilution checkerboard and time-kill methods

Rodjun V, Houngsaitong J*, Montakantikul P, Paiboonvong T, Khuntayaporn P, Yanyongchaikit P, Sriyant P..
Antibiotics 2020; 9(8): 516: 1-10., 2020.

30.

Microbial epidemiology and risk factors for relapse in gram-negative bacteria catheter-related bloodstream infection with a pilot prospective study in patients with catheter removal receiving short-duration of antibiotic therapy

Surapat B, Montakantikul P, Malathum K, Kiertiburanakul S, Santanirand P, Chindavijak B*..
BMC infectious diseases 2020; 2(1): 604., 2020.

31.

Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection)

Tidwong N*, Montakantikul P, Manosuthi W..
Pharmaceutical sciences asia 2020; 47(2): 26: 97-103., 2020.

32.

Prevalence of OXA-Type β-lactamase genes among carbapenem-resistant acinetobacter baumannii clinical isolates in Thailand

Thirapanmethee K, Srisiri-A-Nun T, Houngsaitong J, Montakantikul P, Khuntayaporn P, Chomnawang MT*..
Antibiotics (basel) 2020; 9(12): 864., 2020.

Year 2019

33.

Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a university hospital in Thailand

Prakobsrikul N, Malathum K, Santanirand P, Chumnumwat S, Piebpien P, Montakantikul P*..
Journal of Clinical Pharmacy and Therapeutics 2019; 44(2): 292-299, 2019.

34.

Optimization of intermittent vancomycin dosage regimens for Thai Critically Ill Population Infected by MRSA in the Era of the "MIC Creep" Phenomenon

Setiawan E, Suwannoi L, Montakantikul P, Chindavijak B..
ACTA MEDICA INDONESIANA 2019;51(1):10-18, 2019.

35.

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin against carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Escherichia coli

Jitaree K, Sathirakul K*, Houngsaitong J*, Asuphon O, Saelim W, Thamlikitkul V, Montakantikul P*..
Antibiotics 2019; 8(3); 125., 2019.

36.

Pharmacokinetics and penetration of sitafloxacin into alveolar epithelial lining fluid in critically ill Thai patients with pneumonia

Paiboonvong T, Nosoongnoen W*, Sathirakul K*, Tangsujaritvijit V, Kaemapairoj J, Tragulpiankit P*, Montakantikul P*..
Antimicrob Agents Chemother 2019; 63(10)., 2019.

37.

Prognostic value of serum procalcitonin level for the diagnosis of bacterial infections in critically-ill patients

So-Ngern A, Leelasupasri S, Chulavatnatol S, Pummangura C, Bunupuradah P, Montakantikul P.
Infection and Chemotherapy 2019;51(3):263-273. doi: 10.3947/ic.2019.51.3.263, 2019.

Year 2018

38.

Dyslipidemia Among Thai HIV-Infected Adults Receiving Antiretroviral Therapy: A Hospital-Based Report.

So-Ngern A, Khan-asa B, Montakantikul P, Manosuthi W*..
Southeast Asian Journal of Tropical Medicine and Public Health 2018; 49(1): 60-67., 2018.

39.

Education on antimicrobials, antimicrobial resistance, and infectious diseases in pharmacy curricula, Thailand

Paiboonvong T, Pummangura C, Tedtaisong P, Thamlikitkul V, Tragulpiankit P, Suansanae T, Sukkha S, Montakantikul P.*.
Pharmaceutical Sciences Asia 2018; 45(2): 105-113, 2018.

40.

Pharmacodynamic evaluation of oral amoxicillin, amoxicillin/clavulanate, cefditoren, and azithromycin against streptococcus pneumoniae-caused respiratory tract infections: A monte carlo simulation

Jannual S, Montakantikul P, Houngsaitong J, Thamlikitkul V, Sonthisombat P.*.
Journal of the Medical Association of Thailand 2018; 101(3): 305-312, 2018.

41.

Pharmacokinetic and pharmacodynamic approach in adult critically-ill patients treated with standard dose of vancomycin for MRSA infection

Setiawan E, Montakantikul P.*.
Journal of the Medical Association of Thailand 2018; 101(5): 555-562, 2018.

Year 2017

42.

Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study

Sukkha S, Chindavijak B, Montakantikul P, Ingsathit A, Nosoongnoen W*, Sumethkul V..
International Journal of Clinical Pharmacy. 2017; 39(6): 1298-1303., 2017.

Year 2016

43.

Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation

Asuphon O, Montakantikul P, Houngsaitong J, Kiratisin P, Sonthisombat P*..
International Journal of Infectious Diseases 2016; 50: 23-29., 2016.

Year 2015

44.

Synergistic effects of fosfomycin and carbapenems against carbapenem-resistant Pseudomonas aeruginosa clinical isolates

Kunakonvichaya B, Thirapanmethee K., Khuntayaporn P, Montakantikul P, Chomnawang MT*..
International Journal of Antimicrobial Agents 2015; 45(5): 556-557, 2015.

Year 2014

45.

Clinically significant drug interactions amongs HIV-infected patients receiving antiretroviral therapy

So-Ngern A, Montakantikul P, Manosuthi W..
Southeast asian journal of tropical medicine and public health. 2014; 45(5): 1023-1031., 2014.

46.

Effectiveness of Tobacco Education for Pharmacy Students in Indonesia

Kristina SA*, Thavorncharoensap M, Pongcharoensuk P, Montakantikul P, Suansanae T, Prabandari YS..
Asian Pacefic J Cancer Chemprevantion 2014; 15(24): 10783-10786, 2014.

Year 2013

47.

Molecular investigation of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa isolated clinically in Thailand

Khuntayaporn P, Montakantikul P, Santanirand P, Kiratisin P, Chomnawang MT*..
Microbiology and Immunology 2013; 57(3): 170-178, 2013.

Year 2012

48.

A prospective, randomized, double dummy, placebo-controlled trial of oral cefditoren pivoxil 400 mg once daily as switch therapy after intravenous ceftriaxone in the treatment of acute pyelonephritis

Monmaturapoj T, Montakantikul P, Mootsikapun P*, Tragulpiankit P..
International Journal of Infectious Diseases 2012; 16(12): 843-849, 2012.

49.

Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across Thailand

Khuntayaporn P, Montakantikul P, Mootsikapun P, Thamlikitkul V, Chomnawang MT*..
Annals of Clinical Microbiology and Antimicrobials 2012; 1-7., 2012.

50.

Study of Medication Reconciliation Process in Pediatrics Medical Wards at Queen Sirikit National Institute of Child Helath.

Bhumibhamon N, Montakantikul P, Sangtawesin V, Suksomboon N..
Thai Pediatric Journal 2012; 19(1): 23-30., 2012.

Year 2011

51.

Measured versus estimated creatinine clearance in elderly patients

Tragulpiankit P, Montakantikul P, Chulavatnatol S, Chansirikarnjana S, Thawinwang A..
Journal of Applied Therapeutic Research 2011; 8(2): 43-51, 2011.

Year 2009

52.

Effects of changes in patients’ nutritional status upon complications, clinical outcomes, length of hospital stay and hospital expense

Chindavijak B, KomindrS, Ritsri W , Montakantikul P..
Thai Journal of Clinical Nutrition 2009; 3(2): 81-5., 2009.

53.

Incidence of Medication Errors in Medication Reconciliation at General Medical Wards, Ramathibodi Hospital

Paiboonvong T, Montakantikul P*, Chansirikarnjana S, Tragulpiankit P..
Mahidol J Pharm. Sci 2009; 36(1-4): 44-49., 2009.

Year 2007

54.

Drug Therapy Problem Management by Pharmacist in Paediatric Intensive Care Unit at a Large Teaching Hospital, Thailand

Piebpien P, Tragulpiankit P, Preutthipan A, Montakantikul P..
Drug Safety 2007; 30(10): 949, 2007.

Year 2005

55.

Prevention of adverse drug reactions in hospitalised patients by pharmacist participation at a large teaching hospital in Thailand.

Tragulpiankit P, Pummangura C, Luscombe DK, Kaojarern S, Wananukul W, Montakantikul P, Nathisuwan S..
Drug Safety 2005;28(10):931., 2005.

Year 2004

56.

Characteristics of adverse drug reactions and patient at risk in medical wards.

Pummangura C, Tragulpiankit P, Kaojarern S, Wananukul W, Montakantikul P, Luscombe DK, Pomyen N. .
Pharmacy World & Science 2004;26:A100., 2004.

57.

การสำรวจการยอมรับและความคิดเห็นของเภสัชกรต่อการศึกษาต่อเนื่องทางเภสัชศาสตร์

มนทรัตม์ ถาวรเจริญทรัพย์ ปรีชา มนทกานติกุล พัชราภรณ์ เยี่ยมสวัสดิ์ วีนัส ขุติมานิตสกุล.
วารสารเภสัชกรรมโรงพยาบาล 2547; 14(3): 225-233, 2004.

58.

การให้คำปรึกษาด้านผลิตภัณฑ์สมุนไพรของเภสัชกรชุมชน.

สมภพ ประธานธุรารักษ์, ศรัณย์ กอสนาน, ปรีชา มนทกานติกุล, นริศรา เทวพันธ์กุล, มีนา ผจงรักษ์..
วารสารวิชาการสาธารณสุข 2547; 13: 804-12., 2004.

Year 2003

59.

Characteristics of adverse drug reactions and patients at risk in medical wards, Ramathibodi Hospital.

Pummangura C, Tragulpiankit P, Kaojaroen S, Wananukul W, Montakantikul P,Luscombe DK, Pomyen N. .
Mahidol University Journal of Pharmaceutical Sciences 2003;30(3):25-31., 2003.

Year 1998

60.

The Safety of Antituberculosis Medications during Breastfeeding

Tran JH, Montakantikul P.
Journal of Human Lactation 1998; 14(4): 337-340, 1998.


Presentation

Year 2017

1.

In Vitro Synergistic Activity of Biapenem Combination with Sulbactam, Colistin, and Fosfomycin Sodium Against Multidrug-resistant Acinetobacter baumannii Isolates from Tertiarycare Hospitals in Thailand

Houngsaitong J, Montakantikul P, Paiboonvong T, Chomnawang M.
Frontiers in Plant Science Open Forum Infect Dis. 2017 Fall; 4(Suppl 1): S479–S480., 2017.

Year 2016

2.

The association between trough blood concentration and systemic exposure of tacrolimus: Comparison between once-daily (Advagraf®) and twice-daily (Prograf®) formulation

Sukkha S, Ingsathit A, Chindavijak B, Montakantikul P, Nosoongnoen W, Sumethkul V.
Frontiers in Plant Science Transplantation. 2016. 100(Suppl 7S-1): P1509., 2016.

Year 2014

3.

Relationship between antimicrobial consumption and antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Acinetobacter baumannii at a hospital from 2007-2013

Tedtaisong P*, Montakantikul P, Gorsanan S, Tantisiriwat W..
Mahidol University Research Expo 2014 "MU Look to the Future" 1st - 2nd December 2014 , 2014.

Year 2012

4.

A Review of Vancomycin Population Pharmacokinetic Studies in Aduil Critically III Patient

Eko Setiawan, Montakantikul P..
Venturing into ASEAN Community 2015: Bringing up the Cutting Edge of Science & Technology, BP Grand Tower hotelHat Yai, Thailand, on 7-8 December 2012. , 2012.

5.

Assessment of community pharmacists’ knowledge on antimicrobial dispensing for common skin infections

Montakantikul P, Pummangura C, Gorsanan S, Kanjanakachen K, Suckchuang P..
FIP Centennial Congress of Pharmacy and Pharmaceutical Sciences, Netherlands. on 3-8 October 2012 , 2012.

Year 2006

6.

Measured versus estimated creatinine clearance in Thai elderly patients.

Thawinwang A, Montakantikul P, Chansirikarnjana S, Chulavatnatol S, Tragulpiankit P..
งานประชุมวิชาการประจำปี สมาคมเภสัชกรรมโรงพยาบาล (ประเทศไทย) เรื่อง ”The Next Step of Hospital Pharmacist to Quality Pharmacy Service” ณ อาคารเฉลิมพระบารมี ๕๐ ปี แพทยสมาคมฯ กรุงเทพฯ วันที่ 17 - 19 พฤษภาคม พ.ศ. 2549. 2006, 2006.

เกี่ยวกับภาควิชา

The ultimate success of a pharmacist's practice relies on applying expertise to minimize the consumer's risk of harm from medication while maximizing the positive outcomes in disease prevention and treatment.

The ultimate success of a pharmacist's practice relies on applying expertise to minimize the consumer's risk of harm from medication while maximizing the positive outcomes in disease prevention and treatment.
Pradit Hutangura
The First Dean of Faculty of Pharmacy, Mahidol University
Copyright © 2021 - 2026
Division of Information Technology and Instructional Media, Faculty of Pharmacy, Mahidol University.
Cookie Notice
This site uses cookies from us and our partners to make your browsing experience more efficient, relevant, convenient and personal. In some cases, they are essential to making the site work properly. By accessing this site, you direct us to use and consent to the use of cookies. You can change your settings by clicking on the Cookie Settings link.